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Abstract
Reduced protein stability in vivo is a prerequisite to aggregation. While this is merely a nuisance
factor in recombinant protein production, it holds a serious impact for man. This review focuses
on specific approaches to selectively determine the solubility and/or stability of a target protein
within the complex cellular environment using different detection techniques. Noninvasive
techniques mapping folding/misfolding events on a fast time scale can be used to unravel the
complexity and dynamics of the protein aggregation process and factors altering protein solubility
in vivo. The development of approaches to screen for folding and solubility in vivo should facilitate
the identification of potential components that improve protein solubility and/or modulate
misfolding and aggregation and may provide a therapeutic benefit.
Introduction
The protein folding problem has challenged scientists for
more than three decades. The process of folding has been
studied extensively in the test tube, commonly carried out
at low protein concentrations in order to minimize any
parallel off-pathway aggregation processes. The environ-
ment, however, that a newly synthesized protein encoun-
ters in the cell is far from these idealized in vitro
conditions. The intracellular space presents a highly
crowded limited volume predicted to favor association
processes [26]. Given the potential for intermolecular
interactions with other cellular components, the kinetic
and thermodynamic parameters of folding/unfolding
processes in the cell may be quite different from those
ideal in vitro solutions. The complex intracellular environ-
ment significantly affects thermodynamic stability
through changes in the local osmolarity and oxidation
potential in response to stress conditions [3,25]. Reduced
protein stability is detrimental to function and can lead to
aggregation or degradation [2].
There are multiple instances where low in vivo stability of
a protein can lead to negative outcomes. Recombinant
protein production faces difficulties producing some pro-
teins in an active form in expression hosts. Unfortunately,
many recombinant proteins are not efficiently expressed
in a folded or soluble form, which is an obstacle for the
pharmaceutical industry and biotechnology. Protein-fold-
ing diseases are yet another area where protein solubility
plays an important role. Aberrant folding and stability in
the cell is associated with the pathology of many neurode-
generative diseases (e.g., Alzheimer's, Huntington's, Par-
kinson's disease) [2,16]. Solubility and folding efficiency
of a protein can be maintained by sequence alterations,
which necessitate a significant structural knowledge about
the protein of interest to choose appropriate amino acids
for mutation. As a result, there is an urgent need to
develop methods to accurately monitor folding and
unfolding events on fast timescales, directly in living cells.
Such efficient selective methods to monitor folding and/
or solubility in vivo could be also used to assay for com-
pounds inhibiting aggregation and screening for variants
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with an improved solubility by natural or induced
mutations.
In-Cell Spectroscopy
The potential of the nuclear magnetic resonance (NMR)
technique, widely used in vivo for identification of small
molecules, has been extended towards determination of
the conformation of proteins inside living cells [10,17].
The chemical shifts as a specific fingerprint of the local
environment of the atomic nuclei within a protein pro-
vide residue specific information on the conformational
changes due to unfolding or binding events, or other post-
translational modifications. Studies using [15N,1H]-
HSQC [18,19] or magic angle spinning binding experi-
ments [10] have been used to characterize cytoplasmic
and periplasmic biomolecules in bacterial strains. The in
vivo  NMR-spectra detect additional conformations not
observable in in vitro purified samples: The in-cell spec-
trum of calmodulin reveals different occupation of the
four calcium binding sites that is connected to the tight
regulation of the intracellular calcium concentration [19].
A crucial factor, however, that limits the application of the
in-cell NMR experiments is the rotational correlation time
or tumbling rate of the protein in the cellular environ-
ment. The intracellular space is highly viscous and
decreases the tumbling rate, causing a broadening of the
peaks or even their disappearance. The introduction of the
TROSY approach [13] has increased the molecular weight
range of proteins that are amenable to NMR spectroscopy
beyond the 100 kDa mark. This can be applied to virtually
any protein, but there is still the viscosity limit of the
intracellular space.
An interesting twist using conventional mass spectrome-
try technique, widely applied to the determination of con-
formational states of proteins, is a method to measure the
Stability of Unpurified proteins from rates of H/D
exchange (SUPREX) developed by Oas and coworkers [5].
This approach enables the determination of protein sta-
bility directly in the cell. This technique is a variant of the
Matrix-assisted laser desorption/ionization (MALDI)
mass spectrometry [4] and determines the protein stabil-
ity in vivo by measuring the hydrogens that exchange with
solvent deuterons at a rate depending on the thermody-
namic stability of the protein [5]. The SUPREX approach
has been applied to estimate the folding thermodynamics
by direct in-cell urea titration. The thermodynamic stabil-
ity of the small monomeric N-terminal fragment of λ
repressor (λ6–85) estimated with this technique shows no
change in stability versus measurements made in vitro [5].
Additionally, the effects of introduced mutations can be
quantified as changes of the free energy (∆∆Go
N-M)
between the native and unfolded states of mutated pro-
tein (∆Go
M) compared to the wild-type counterpart
(∆Go
N). The bacterial cells are viable up to 3 M urea,
which is sufficient to map the entire unfolding transition
curves  in vivo. Although some successful examples to
determine conformational changes and stabilities have
been reported so far, both techniques, NMR and mass
spectrometry, are far from being established as routine
tests for estimating the in vivo stability. A serious limita-
tion arises if the target protein interacts with any cellular
components (e.g., chaperones, DNA, membranes).
Protein-Reporter-Based Approach
The fusion of a protein of interest to a reporter protein
whose function depends on the solubility of the chimera
has been successfully used to reveal in vivo protein stabil-
ity and folding efficiency, provided the reporter does not
change the solubility of the target protein [Fig. 1 is a car-
toon summarizing different tagging approaches]. Here,
the term solubility is used interchangeably with folding,
and it denotes both the chemical solubility of the folded
native state and the absence of aggregation due to mis-
folding events. This technique is based on the attachment
of a specific protein tag that equips the resulting chimera
with a unique property that can be exploited to monitor
certain functions of the target protein in vivo. Davidson
and coworkers used the resistance against chlorampheni-
col generated by fusing chloramphenicol acetyltransferase
(CAT, 25 kDa) to the C-terminus of the protein of interest
to select soluble variants from a large pool of mutants cre-
ated by a random mutagenesis [11].
A specific implementation of the reporter-based approach
is the structural complementation that involves the split-
ting of the reporter protein into two components that
need to combine to execute their function. Wigley et al.
[23] have designed an elegant assay for monitoring of the
solubility/folding based on complementarity of two frag-
ments originating from β-galactosidase. The α-fragment
of  β-galactosidase, typically 50–90 residues in length,
when attached C-terminally to the protein of interest, can
complement its ω-fragment, coexpressed in the soluble
cytoplasmic fraction, to reconstitute the functional pro-
tein. The assembly occurs only if the target protein is
expressed in the soluble form and the complementation
event restores the enzymatic functions. The relatively
small size of the α-peptide does not perturb the structure
of the target proteins and does not have any dramatic
effect on the solubility of the chimera [23]. As a bimolecu-
lar reaction the assembly is significantly affected by the
concentration of the complementing parts and is deter-
mined by the equilibrium association/dissociation con-
stant Kd, which is a significant hurdle to study kinetics of
folding/aggregation. An advantage this system shares with
the CAT-based system is the potential for using an easily
detectable phenotypic selection for screening of mutants
with improved folding efficiency.Microbial Cell Factories 2005, 4:23 http://www.microbialcellfactories.com/content/4/1/23
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An alternative to the complementarity principle is the
split-technique by which target protein is tagged at both
termini with two halves of the reporter protein [9]. The
protein of interest is sandwiched between the two halves
of ubiquitin, which assemble into a functional ubiquitin
moiety only after an accomplished folding of the target
protein [15]. The reconstituted ubiquitin serves as a sub-
strate of ubiquitin-specific proteases, normally present in
Strategies for site-specific labeling of proteins to detect folding and stability in vivo Figure 1
Strategies for site-specific labeling of proteins to detect folding and stability in vivo. (A) The autofluorescent green protein is 
appended to the protein of interest (here maltose-binding protein) and the latter dictates the spectroscopic behavior of the 
protein-reporter tag. The same fusion scheme applies for enzymes (e.g., CAT) whose activity serves as readout of the analysis. 
(B) Complementation assay. The target protein (here maltose-binding protein) is sandwiched between two reporter proteins 
or between the two halves of one reporter. Efficient folding brings both parts of the reporter unit into sufficient proximity to 
generate a readout signal. (C) Small-molecule labeling using peptide tags. The peptide tag can be introduced in the middle of the 
protein sequence (here cellular retinoic acid binding protein with a tetracysteine motif highlighted in yellow and FlAsH ligated 
to it) and the intensity of the emitted fluorescent signal can be used to determine conformationally distinct populations, pro-
vided the specific signatures of the folded and unfolded states are pre-determined for each experiment.Microbial Cell Factories 2005, 4:23 http://www.microbialcellfactories.com/content/4/1/23
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the cytosol and the nucleus of all eukaryotic cells, and the
release of the reporter from the chimera is the readout of
the assay. Detection is accomplished ex vivo after the inter-
molecular association event has taken place. It may per-
turb the equilibrium established within the cell due to this
physical separation of the cellular components. The
method is qualitative, allowing the study of alterations of
the structure caused by mutations or intracellular environ-
ment but it cannot be used for measurements and for
determination of the destabilization energy (∆∆Go
N-M)
caused by the corresponding mutation.
The use of autofluorescent proteins as reporter protein
tags, such as green fluorescent protein (GFP) and its rela-
tives with improved spectral properties, has contributed
greatly to our understanding of intracellular trafficking,
localization and protein-protein interactions that could
not have been achieved with other technologies [20]. The
autocatalytically-generated broad fluorescent signal of
GFP is easily detectable in a bulk cell suspension or under
the microscope, and this key feature makes it an attractive
fusion counterpart for studying intracellular folding and
unfolding processes. Waldo and coworkers [21] showed
that the folding trajectory of a protein of interest fused
upstream to the GFP dictates its fluorescent behavior and
the emitted fluorescent signal is directly proportional to
the amount of the correctly folded protein. Later on,
Glockshuber and coworkers [14] propose an approach for
monitoring of protein solubility based on in vivo Förster-
resonance-energy-transfer (FRET) measurements of two
proteins, reminiscent of the idea of the complementation
assay. The target protein is labeled at both termini with
GFP and its blue-shifted variant, BFP, and efficient folding
brings both fluorescent proteins into sufficient proximity
to generate a FRET-signal. The readouts of the fluorescent
reporter protein-based methods for protein solubility in
vivo are simply detectable signals and allow a fast selection
of the soluble variants of any protein of interest. Although
enhanced variants of GFP with significantly accelerated
folding and fluorescence acquisition have been devel-
oped, unfortunately, their bulky size (238 amino acids)
may perturb the structure of the target protein. The rela-
tively long folding trajectory of GFP itself ranging from
minutes to hours [6], even of the improved Venus or T-
Sapphire variants, is out of the time window of early
intramolecular (folding) and intermolecular (aggrega-
tion) events. Furthermore, large surface contacts between
the target protein molecules (e.g. protein aggregation) can
undesirably alter the fluorescence of the reporter [24].
All reporter-based approaches monitor the protein fold-
ing and the solubility as a result of efficient folding at its
equilibrium. For understanding the mechanisms of pro-
tein misfolding in the cell and its impact for disease and
biotechnology, it is necessary to follow the process from
its early initial steps. Insertion of the reporter molecule
within the sequence of the target protein can probably
capture early folding/unfolding events. Unfortunately, the
bulky reporter proteins can be appended only to either the
N- or C-terminus. Short peptide sequences that mediate
the labeling of the protein of interest with small synthetic
molecules, conferring unique spectroscopic properties,
present an alternative solution to overcome these restric-
tions. Such approaches are discussed in the next section.
Lighting-up Folding Processes with Small 
Molecules
The prototype for the in vivo labeling of fusion proteins
with small synthetic molecules is based on the formation
of stable complexes between biarsenical derivatives of flu-
orescein (FlAsH) or resorufin (ReAsH) and peptides con-
taining tetracysteine motif developed in the lab of Roger
Tsien [1,7]. The two arsenoid groups of the dye selectively
coordinate the four cysteine residues from the naturally
uncommon tetracysteine motif (Cys-Cys-Xaa-Xaa-Cys-
Cys, where Xaa denotes any amino acid, preferably Pro-
Gly, [1]), which can be incorporated at virtually any place
in the target protein sequence due to the small size. The
dye ligand is membrane permeable and non-fluorescent;
however it emits an intense fluorescent signal upon high
affinity binding to the cysteine residues (2–4 pM Kd [1]).
The background fluorescence can be minimized by treat-
ment of the cells with ethane dithiol that pairs the
unpaired cysteines from endogenous proteins displaying
a weak affinity for FlAsH.
Dye ligation to the tetracysteine receptor is not connected
to a characteristic emission shift that can be used as a spe-
cific fingerprint for detection of a distinct conformational
species. Incorporation of the tetracysteine sequence in
flexible structural regions (e.g., loops) within the protein
sequence of the cellular retinoic acid binding protein,
however, leads to a significant sensitivity of the dye quan-
tum yield on the conformational state of the host protein,
with a denatured state hyperfluorescent compared to the
native one [8]. The FlAsH-mediated fluorescence lacks
specific quantum yields repeatedly observed for distinct
conformational populations and the frame conditions
(e.g., intensity of folded and unfolded state) need to be
determined for each protein. Upon a set-up of these frame
conditions the intensity of the FlAsH fluorescence can be
used to capture early misfolding events and to monitor
the time course of aggregate formation, provided the
FlAsH has been internalized in the cells before induction
of the protein synthesis [8]. The key advantage of this sys-
tem is that it allows to follow the whole protein folding
history, starting from the early misfolding events assumed
to generate the most toxic species in the aggregation proc-
ess. Moreover, the FlAsH-mediated fluorescence can be
used to monitor the equilibrium stability of a protein ofMicrobial Cell Factories 2005, 4:23 http://www.microbialcellfactories.com/content/4/1/23
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interest by direct in-cell urea titration [8], allowing thus to
determine the direct effect of a mutation on the protein
stability and the aggregation propensity of mutants.
Recent improvements of the original FlAsH-methodology
have expanded the utility of this approach, providing a
powerful tool for studying conformational dynamics in
vivo. Nakanishi and coworkers [12] modified the bensoic
acid moiety and developed another biarsenical analog of
the Nile red (BarNile) with an environmentally sensitive
fluorophore used to monitor conformational changes
caused by binding of metal ions. The FlAsH-based tech-
niques hold a great promise as a tool for study the protein
misfolding and aggregation kinetics in the cell with a time
window tracking the early aggregation phases.
Conclusions and Future Perspectives
Off-pathway misfolding and aggregation are highly unde-
sirable processes both reflecting the cell's fitness, resulting
in physiological dysfunctions (e.g., neurodegeneration),
and the production of recombinant proteins. In vivo inves-
tigations, in the same background the newly synthesized
protein encounters, are tremendously helpful to elucidate
the mechanisms of protein folding/misfolding. The gen-
eral need, however, goes towards detecting soluble and
insoluble species after the biosynthesis process has
reached equilibrium. Besides the development of meth-
ods with easy readouts, the approaches have to be concep-
tually focused on spanning the time window towards the
early folding/unfolding events. Real-time kinetic studies
are necessary to track the entire process and they will
accelerate the development of strategies to suppress the
undesired off-pathway unfolding reactions. In addition to
understanding the mechanisms of folding and aggrega-
tion within the cell, the direct monitoring of the protein
solubility  in vivo has wide practical applicability. For
instance, in the recombinant production of proteins, cul-
ture conditions can be modulated and optimized by mon-
itoring their direct effect on the protein solubility. Of
particular interest would be to engineer expression hosts,
e.g., use of bacterial strains deficient in certain intracellu-
lar proteases, or strains with up-regulated expression of
cellular chaperones and to follow in real time their influ-
ence on the recombinant protein production. The direct
monitoring of the folding ability in vivo opens up the pos-
sibility of high-throughput screening for the production
of proteins with improved solubility by random mutagen-
esis and facilitating the design of novel protein structures.
Acknowledgements
The author is a recipient of the Heisenberg fellowship of the DFG (IG 73/
1-1). I appreciate critical reading and fruitful discussion of the manuscript by 
Lila Gierasch, Kenneth S. Rotondi, Joanna Swain, and Beena Krishnan.
References
1. Adams SR, Campbell RE, Gross LA, Martin BR, Walkup GK, Yao Y,
Llopis J, Tsien RY: New biarsenical ligands and tetracysteine
motifs for protein labeling in vitro and in vivo: synthesis and
biological applications.  J Am Chem Soc 2002, 124:6063-6076.
2. Dobson CM: Protein misfolding, evolution and disease.  Trends
Biochem Sci 1999, 24:329-32.
3. Frand AR, Cuozzo JW, Kaiser CA: Pathways for protein disul-
phide bond formation.  Trends Cell Biol 2000, 10:203-210.
4. Ghaemmaghami S, Fitzgerald MC, Oas TG: A quantitative high-
throughput screen for protein stability.  Proc Natl Acad Sci U S A
2000, 97:8296-8301.
5. Ghaemmaghami S, Oas TG: Quantitative protein stability meas-
urement in vivo.  Nat Struct Biol 2001, 8:879-882.
6. Heim R, Cubitt AB, Tsien RY: Improved green fluorescence.
Nature 1995, 373:663-664.
7. Griffin BA, Adams SR, Jones J, Tsien RY: Fluorescent labeling of
recombinant proteins in living cells with FlAsH.  Methods
Enzymol 2000, 327:565-578.
8. Ignatova Z, Gierasch LM: Monitoring protein stability and
aggregation in vivo by real-time fluorescent labeling.  Proc Natl
Acad Sci U S A 2004, 101:523-528.
9. Johnsson N, Varshavsky A: Split ubiquitin as a sensor of protein
interactions in vivo.  Proc Natl Acad Sci U S A 1994, 91:10340-10344.
10. Wieruszeski JM, Bohin A, Bohin JP, Lippens G: In vivo detection of
the cyclic osmoregulated periplasmic glucan of Ralstonia
solanacearum by high-resolution magic angle spinning NMR.
J Magn Reson 2001, 151:118-123.
11. Maxwell KL, Mittermaier AK, Forman-Kay JD, Davidson AR: A sim-
ple in vivo assay for increased protein solubility.  Prot Sci 1999,
8:1908-1911.
12. Nakanishi J, Maeda M, Umezawa Y: A new protein conformation
indicator based on biarsenical fluorescein with an extended
benzoic acid moiety.  Anal Sci 2004, 20:273-278.
13. Pervushin K, Riek R, Wider G, Wuthrich K: Attenuated T2 relax-
ation by mutual cancellation of dipole-dipole coupling and
chemical shift anisotropy indicates an avenue to NMR struc-
tures of very large biological macromolecules in solution.
Proc Natl Acad Sci U S A  1997, 94:2366-12371.
14. Philipps B, Hennecke J, Glockshuber R: FRET-based in vivo screen-
ing for protein folding and increased protein stability.  J Mol
Biol 2003, 327:239-49.
15. Raquet X, Eckert JH, Muller S, Johnsson N: Detection of altered
protein conformations in living cells.  J Mol Biol 2001,
305:927-938.
16. Ross CA, Poirier MA: Protein aggregation and neurodegenera-
tive disease.  Nat Med 2004, 10:S10-S17.
17. Serber Z, Dötsch V: In-cell NMR spectroscopy.  Biochemistry 2001,
40:14317-14323.
18. Serber Z, Keatinge-Clay AT, Ledwidge R, Kelly AE, Miller SM, Dötsch
V:  High-resolution macromolecular NMR spectroscopy
inside living cells.  J Am Chem Soc 2001, 123:2446-2447.
19. Serber Z, Ledwidge R, Miller SM, Dötsch V: Evaluation of param-
eters critical to observing proteins inside living Escherichia
coli cells by in-cell NMR spectroscopy.  J Am Chem Soc 2001,
123:8895-8901.
20. Tsien RY: The green fluorescent protein.  Annu Rev Biochem 1998,
67:509-544.
21. Waldo GS, Standish BM, Berendzen J, Terwilliger TC: Rapid pro-
tein-folding assay using green fluorescent protein.  Nat
Biotechnol 1999, 17:691-695.
22. Wieruszeski JM, Bohin A, Bohin JP, Lippens G: In vivo detection of
the cyclic osmoregulated periplasmic glucan of Ralstonia
solanacearum by high-resolution magic angle spinning NMR.
J Magn Reson 2001, 151:118-23.
23. Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ: Protein
solubility and folding monitored in vivo by structural comple-
mentation of a genetic marker protein.  Nat Biotechnol 2001,
19:131-6.
24. Wurth C, Guimard NK, Hecht MH: Mutations that reduce aggre-
gation of the Alzheimer's Aβ42 peptide: an unbiased search
for the sequence determinants of Aβ amyloidogenesis.  J Mol
Biol 2002, 319:1279-1290.
25. Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN: Living
with water stress: evolution of osmolyte systems.  Science
1982, 217:1214-1222.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Microbial Cell Factories 2005, 4:23 http://www.microbialcellfactories.com/content/4/1/23
Page 6 of 6
(page number not for citation purposes)
26. Zimmerman SB, Minton AP: Macromolecular crowding: bio-
chemical, biophysical, and physiological consequences.  Annu
Rev Biophys Biomol Struct 1993, 22:27-65.